Optimise your clinical practice with Omnipod® 5
Optimise your clinical workflow
Flexible, efficient approaches for initiating and ensuring better outcomes on Omnipod 5
Explore flexible onboarding models
Starting patients virtually
Virtual starts can allow patients to complete their Omnipod 5 training online from the comfort of their own home. They can start uploading their first-day data remotely and give you immediate insight without an in-clinic visit.
The Omnipod 5 Starter Kit and Omnipod 5 Pods will be sent to your patient’s home. Remember to ensure a vial of compatible rapid acting insulin is prescribed.*
To learn more about starting patients virtually, discuss with your Omnipod Specialist or connect now.
*NovoLog® / NovoRapid®, Humalog® / Liprolog®, Admelog® / Insulin lispro Sanofi®, Trurapi® / Insulin aspart Sanofi®, and Kirsty® U-100 insulin are compatible with the Omnipod 5 System for use up to 72 hours (3 days).
Starting patients in a group
Small-group sessions can let you train several patients at once, shortening individual chair time while fostering peer-to-peer encouragement and shared troubleshooting tips.
Watch this webinar for a deep dive into Automated Insulin Delivery (AID) training guidance, virtual learning, and boosting clinical efficiency.
One-time account linking is all you need
Once your patient links their Omnipod ID to a Glooko® account and enters your ProConnect code, their pump and sensor data flow automatically into your clinic portal, ensuring continuous access for ongoing care.
Have a data-management question about Omnipod 5? Visit our dedicated FAQs page.
Streamline your clinic’s process with remote monitoring and virtual follow-ups
Remote monitoring for
streamlined follow-ups
By reviewing each patient’s real-time Omnipod 5 and CGM data in Glooko® before an appointment, you can save time during follow-up visits and focus only on interpretation and action, rather than data collection.
Virtual follow-ups for convenience
By hosting a video call and sharing the Glooko® report on-screen, you can walk through time-in-range (TIR), insulin totals, and recent events together with your patient; then make any therapy adjustments in a single, streamlined session.
PANTHERTOOL® CARES framework turns Glooko® metrics into quick, actionable adjustments
Use Glooko® to view real-time data, generate reports, and support personalised treatment decisions.
Optimise Omnipod 5 system settings
Fine-tuning the adjustable settings and data insights to personalise therapy and improve glycaemic control.
Key adjustable settings
While SmartAdjust™ technology automatically adjusts insulin delivery, you may adjust the following settings for personalised patient needs.
- Target Glucose
Sets the target that the algorithm steers glucose toward every five minutes; choose a value between 6.1 and 8.3 mmol/L (110–150 mg/dL) to match your patient’s goals.
Example scenario: If you notice recurring rises in glucose during certain times of the day, consider lowering the patient’s Target Glucose during those hours for tighter control.
- Insulin-to-Carbohydrate (IC) Ratio and Correction Factor
These settings determine how much bolus insulin is delivered for meals and for high-glucose corrections, helping to keep post-meal spikes in check.
Example scenario: When high-carb dinners cause after-meal spikes, the IC Ratio can be strengthened specifically for the dinner block to deliver a stronger bolus. Or, for repeated late-evening lows following correction doses, the Correction Factor can be weakened so the bolus calculator provides smaller corrections.
- Duration of Insulin Action (DIA)
This defines how long insulin remains active in dosing calculations, preventing insulin stacking which can lead to lows.
Example scenario: If a patient is experiencing mid-afternoon lows from “double dosing” on corrections, lengthen the DIA so that the system recognises more insulin-on-board before recommending another bolus.
Spot trends and refine therapy with Glooko® and PANTHERTOOL®
- The Glooko® Summary Report instantly shows TIR and basal-to-bolus split, giving you a snapshot of overall control.
- The Device Settings Report tracks every change to pump parameters, so you can see exactly who adjusted what and when.
- Apply the PANTHERTOOL® CARES framework (Collect, Assess, Review, Educate, and Set goals) to turn key Glooko® metrics into targeted setting tweaks in under five minutes.
- Easily prioritise different aspects of individual patient care with PANTHERPointers™. See the PANTHERTOOL® here.
Navigate clinical scenarios with confidence
Help your patients better manage things like exercise, sick days, hypoglycaemia, and the Limited Automated Mode.
Managing Omnipod 5 during exercise and physical activity
Let patients know how to turn on the Activity Feature. It sets the Target Glucose to 8.3 mmol/L (150 mg/dL) regardless of target settings and reduces AID.
Tell them that the Activity Feature should be turned on 1-2 hours before the workout to reduce exercise-induced lows.
Watch the expert-led webinar about the latest data and new EASD & ISPAD clinical consensus statement on AID and exercise—with tips that you can apply in practice.
Read the full AID and Exercise consensus report for information on different activity types.
What to do when Automated Mode is Limited
Advise your patients to check Pod-sensor placement first; line-of-sight disruptions can pause system automation.
Tell them to check and see if there has been a temporary loss of Pod-sensor communication due to environmental interference.
They may also choose to switch to Manual Mode to start their Basal Programme.
See the Technical User Guide for more information.
Troubleshooting frequent hypoglycaemia
Advise patients to check and adjust the following settings as needed:
- Is the Pod in Automated Mode or Manual Mode?
- If in Manual Mode, is the correct Basal Programme in progress?
- If in Manual Mode, is the Temp Basal (if active) appropriate?
- Is Target Glucose appropriate?
Enquire about patient’s physical activities:
- Has their exercise been unusually long or strenuous?
- Have they been unusually physically active? (e.g., extra walking, housework, heavy or repetitive tasks, lifting, or carrying?)
- Did they use the Activity feature?
- Did they use a decreased Temp Basal during this activity, if using the system in Manual Mode?
- Did they consume carbs before, during, and/or after activity?
Enquire about patient’s meals or snacks:
- Did they count the carbs correctly including subtracting significant fibre?
- Did they bolus with food?
- Did they consume alcohol?
Consult the User Guide for more information.
If the patient is experiencing patterns of hypoglycaemia, the following solutions may be implemented:
- Pattern: Around mealtime (1–3 hours after meals)
- Solution: Assess carb counting accuracy, bolus timing, and meal composition. Weaken I:C Ratio by 10–20% (e.g. if 1:10 g, change to 1:12 g)
- Pattern: Low glucose follows high glucose
- Solution: If due to bolus calculator overrides, educate patient to follow the bolus calculator and avoid overriding to give more than recommended. They may be unaware of a lot of IOB from AID. Bolus calculator factors in IOB from increased AID when calculating correction bolus dose. Weaken correction factor by 10–20% (e.g. if 1:2.8 mmol/L, change to 1:3.3 mmol/L) if hypoglycaemia occurs 2–3 hours after.
Download the PANTHERTOOL® for more solutions.
Sick day protocols and adjustments
Advise patients to continue basal insulin and check glucose every 2 hours during illness, adjusting bolus doses as needed while maintaining carb intake.
Instruct them to test ketones whenever glucose ≥13.9 mmol/L (250 mg/dL) or if feeling unwell, since diabetic ketoacidosis can occur even when glucose is in range.
Emphasise aggressive hydration and prompt contact with the clinic if symptoms persist.
See the Technical User Guide for more information.
Learn more about troubleshooting issues like connectivity, glucose control, alarms, and more from these dedicated FAQs.
Watch an expert-led webinar on the AID + Exercise consensus report.
Stay informed on all things Omnipod 5. Sign up to receive the latest updates, clinical education, and product news right to your inbox.
EASD, European Association for the Study of Diabetes; ISPAD, International Society for Pediatric and Adolescent Diabetes.